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EFFECT OF SYSTEMIC DISEASES ON PERIODONTAL
MICROBIOME. A LITERATURE REVIEW. PART III.
Adam Saleh* | Gabriel Menassa** | Carole Chakar***
Abstract
Periodontitis is defined as a chronic inflammatory disease and is mainly caused by a dysbiosis of the periodontal microbiome. Many systemic diseases have
been linked to periodontal disease, and the alteration of the microbiome plays a major role in the pathogenesis. Diabetes has been highly associated with
the increased risk of periodontal disease, as it provides a hyperglycemic microenvironment that heavily influences the periodontal microbiome by reducing its diversity and favoring disease associated bacteria. Rheumatoid arthritis has also been associated with periodontitis, with many studies indicating
microbial shifts in affected individuals without reaching a consensus on the precise nature of dysbiosis. Contradictory and limited number of studies focusing on the effect of other diseases (systemic lupus erythematosus, human immunodeficiency virus, leucocyte adhesion deficiency, liver diseases) on the
periodontal microbiome have been also conducted, and many of them have shown distinct microbial shifts in affected individuals.
Keywords: microbiome – periodontium – periodontitis – diabetes mellitus – rheumatoid arthritis – lupus erythematosus – HIV – liver diseases
IAJD 2022;13(1): 53-62.

EFFET DES MALADIES SYSTÉMIQUES SUR LE MICROBIOME
PARODONTAL. UNE REVUE DE LA LITTÉRATURE. PARTIE III.
Résumé
La parodontite est définie comme une maladie inflammatoire chronique, principalement causée par une dysbiose du microbiome parodontal. De nombreuses maladies systémiques ont été liées à la maladie parodontale, et l’altération du microbiome joue un rôle important dans la pathogenèse. Le diabète
a été fortement associé à une augmentation du risque de la maladie parodontale, puisqu’il fournit un microenvironnement hyperglycémique, qui influence
le microbiome parodontal en réduisant sa diversité, et en favorisant les bactéries associées à la maladie. La polyarthrite rhumatoïde a également été
associée à la parodontite. De nombreuses études ont démontré des altérations microbiennes chez les individus touchés sans parvenir à un consensus
sur la nature précise de la dysbiose. Un nombre limité d’études contradictoires portant sur l’effet d’autres maladies (lupus érythémateux disséminé, virus
de l’immunodéficience humaine, déficit d’adhérence des leucocytes, maladies du foie) sur le microbiome parodontal ont également été menées, et de
nombreuses études ont montré des changements microbiens distincts chez les individus affectés.
Mots clés : microbiome – parodonte – parodontite – diabète – polyarthrite rhumatoïde – lupus érythémateux – VIH –
maladies du foie
IAJD 2022;13(1): 53-62.
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1. Introduction
Periodontitis is defined as “a
chronic multifactorial inflammatory
disease associated with dysbiotic
plaque biofilms and characterized by
progressive destruction of the toothsupporting apparatus”. Its primary features include the loss of periodontal
tissue support, manifested through
clinical attachment loss (CAL) and
radiographically assessed alveolar
bone loss, presence of periodontal
pocketing and gingival bleeding. It is
a major public health problem since
its prevalence is quite high, and it may
lead to tooth loss and disability, negatively affect chewing function and aesthetics, be a source of social inequality,
and impair quality of life. Periodontitis
accounts for a substantial proportion
of edentulism and masticatory dysfunction, results in significant dental
care costs and has a plausible negative
impact on general health. [1].
Two reviews were recently published in the International Arab Journal
of Dentistry (IAJD) describing the norm
and alterations of the periodontal
microbiome (part I) [2], and the periimplant microbiome (part II) [3]. Part
I focuses on the periodontal microbiome during periodontal health, and its
alterations during gingivitis and periodontitis, and quickly mentions some
factors affecting this microbiome, like
tobacco and diabetes.
Studies have shown a significant
two-way relationship between periodontitis and certain systemic diseases and conditions (Figure 1), which
are significant for the dentist in the
daily practice and for a physician as
well [4]. One of the pathways of this
two-way relationship is the alteration
of the oral and periodontal microbiome. This review starts with a recap
about the periodontal microbiome,
and then focuses on the systemic diseases that affect it.

2. Periodontal microbiome
Dental biofilms develop on the
hard surfaces of the mouth, such as
teeth, dentures, and implants. These

dental biofilms form part of the oral
microbiome, which in turn is part of
the human microbiome. Contemporary
studies show that the human microbiome plays an essential role in the
health and well-being of their host.
Humans have evolved to have an
intimate and largely beneficial relationship with these microorganisms;
however, this relationship is dynamic
and fragile, and a number of intrinsic
and extrinsic factors can damage this
exquisite balance, and such events can
lead to disease [6].
The human microbiome plays
a fundamental role in the normal
development of the body and provides significant benefits to the host.
For example, the human microbiome
contributes to the differentiation and
maturation of the host mucosa and its
immune system, to the breakdown of
dietary components and the generation of energy, and to the exclusion of
exogenous microbes, many of which
could be pathogenic [7]. In general,
this relationship is symbiotic, in that
the microorganisms gain a warm and
nutritious environment in which to
grow while delivering the benefits to
the host.
The balance of the microbiome at a
site can be disrupted, which can result
in this synergistic relationship breaking down, and disease can be a consequence: a process called “dysbiosis”
[6].
The mouth is similar to other habitats within the body in having a characteristic microbial community that
provides benefits for the host. The
mouth is warm and moist, and is able
to support the growth of a wide range
of microorganisms, such as viruses,
mycoplasma, bacteria, fungi, and protozoa, but in which bacteria are the
most numerous [8]. These microorganisms colonize mucosal and dental
surfaces in the mouth to form threedimensional, structurally organized
multispecies communities that are
termed “biofilm” [9]. The biofilms that
form on teeth are called dental plaque,
becomes can be calcified and become
“calculus”. The cultivable portion of

the microbiome is also referred to as
the “oral microbiota” [6].
This natural balance is maintained
despite continual surveillance by the
host defenses and the regular exposure of the mouth to a variety of modest environmental stresses, such as
the diet, changes in saliva flow, oral
hygiene, and lifestyle practices such as
smoking (Figure 2a). However, microbial homeostasis can breakdown on
occasions if one of the key parameters
affecting growth is perturbed and is
sufficiently robust or regular to result
in the reorganization of the composition of the biofilm, with the outgrowth
of previously minor components
(Figure 2b). Such perturbations can be
due to immunological (neutrophil dysfunction, immune suppression, etc.) or
non-immunological (xerostomia, diet
change, etc.) factors, and can predispose a site to disease [9].
In summary, the following microbial shifts can be observed when comparing periodontal health to gingivitis
and periodontitis:
From
gram-positive
to
gram-negative
From cocci to rods, and, at a
later stage, to spirochetes
From nonmotile to motile
organisms
From facultative anaerobes to
obligate anaerobes
From fermenting to proteolytic species [10]
The healthy microbiome and its
alterations during gingivitis and periodontist are clearly detailed in the Part I
of the literature review [2].

3.Systemic diseases
affecting the periodontal
microbiome
3.1.
Diabetes
The relationship between periodontitis and diabetes can be described as a
“bidirectional relationship”. Diabetes,
especially if poorly controlled, can
increase the risk of periodontal disease and ultimately tooth loss. On the
other hand, in individuals with diabetes, concurrent periodontitis can
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Figure 1 - Systemic diseases that periodontal disease has been linked to [5].

Figure 2 - Host factors that influence the
microbial composition, activity and stability of the resident oral microbiota. (a) A
number of host factors help to determine the
composition and activity of the natural and
beneficial oral microbiota. (b). A perturbation
in a key environmental factor can disrupt the
natural stability (microbial homeostasis) of
the resident microbiota at a site and result
in a re-arrangement of the composition and
activity of the resident microbial community;
such a change might predispose the site to
disease. [6]

negatively affect glycemic control and
increase the risk of complications of
diabetes [11]. The periodontal microbiome is a key factor in the periodontal
pathogenesis.
Overall, clear reduction of phylogenetic diversity is apparent in the oral
microbiome of diabetic (and prediabetic) patients relative to that of normoglycemic individuals [12].
Comparison
of
periodontally
healthy normoglycemic and diabetic
individuals using principal component analysis found that these groups

of patients could not be clearly distinguished, although the levels of
Pseudomonas sp and Neisseria sp were significantly higher in diabetic patients,
while the level of Corynebacterium
matruchotii, a commensal organism,
was significantly decreased [13].
Periodontally healthy diabetic subjects exhibit significantly lower species
richness than periodontally healthy
controls, as diabetic subjects showed
significantly lower levels of gram-positive facultative species, and higher levels of gram-positive and gram-negative

anaerobic species. Thus, a diseaseassociated community framework is
established in states of periodontal
health in diabetic subjects. This framework is characterized by decreases
in the relative abundance of healthcompatible species, such as Atopobium
and Corynebacterium [14], and increases
in the levels of species belonging to
disease-associated genera (Figure
3), including Porphyromonas, Prevotella,
Campylobacter, and Fusobacterium [15].
Thus, it appears that periodontally
healthy individuals who are diabetic
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Figure 3 - The subject-level comparison of P. gingivalis (Pg), T. forsythia
(Tf), T. denticola (Td) and A. actinomycetemcomitans (Aa) distribution
in gingival sulcus from non-diabetic mellitus (NDM) group, controlled
insulin-dependent type 2 diabetes mellitus (CDM) group and poorly
controlled insulin-dependent type 2 diabetes mellitus (PDM) group. *P
< 0.05 compared to NDM. [15]

are at risk of periodontitis primarily
because of decreases in the relative
abundance and prevalence of healthcompatible species and increases in
the pathogenic content of the hyperglycemic microbiota [12]. Comparisons
between normoglycemic and diabetic
individuals with periodontitis show
that samples from diabetic patients
are distinct from those of normoglycemic individuals [13].
In addition, Ganesan et al. demonstrated that the level of metabolic
control further shapes the periodontal
microbiome, as significant clustering
is observed based on the level of glycated hemoglobin, which is 5% in prediabetic individuals, 6.5%- 9.9% in diabetic individuals, and >10% in those
with uncontrolled diabetes [16].
Most of the differences observed in
normoglycemic and diabetic individuals who have periodontitis are probably influenced by the fact that the
latter exhibit significantly lower species richness, lower levels of anaerobic organisms, and higher levels of
facultative organisms (both grampositive and gram-negative), including Aggregatibacter sp and T forsythia.
The core microbiome of periodontally
heathy diabetic individuals comprised
47 species, 31 of which were not part of
the core of their normoglycemic counterparts. In patients with periodontitis,

out of 81 species that comprised the
core microbiome of normoglycemic
individuals, 46 (primarily species of the
genera Actinomyces, Kingella, Streptococcus,
Corynebacterium, and Gemella, which
are generally recognized as commensals) were not identified in the core
microbiome of diabetic individuals.
In addition, higher levels of species
belonging to the genera Lactobacillus,
Corynebacterium, and Pseudomonas, and
lower levels belonging to the genera
Treponema, Porphyromonas, Prevotella, and
Parvimonas, were observed in diabetic
patients [16].
Furthermore, in a cohort study by
Shi et al. [17], it has been observed that
the shift in composition of the subgingival microbiome from the healthy to
the periodontitis state was less prominent in type 2 diabetic subjects than in
non-diabetic subjects, yet the clinical
signs of disease were similar for both.
They’ve also revealed a highly correlated presence of pathogenic species
in relative abundance not only in the
periodontitis state, but also in the
healthy state in diabetic patients, suggesting an elevated risk of progression
to periodontitis [17].
In a whole metagenomic shotgun
sequencing of the subgingival microbiome done by Farina et al. [18], comparing diabetic to non-diabetic patients
in different periodontal states, it has

been found that genes from red complex species were less prevalent in the
periodontitis state in diabetic subjects than in normoglycemic subjects,
while in the periodontally healthy
state, genes from orange complex species were more prevalent in diabetic
patients.
Overall, data from the literature
shows that the hyperglycemic microenvironment in diabetic patients
reduces the diversity of the periodontal microbiome in periodontal health
compared to normoglycemic healthy
subjects. This microenvironment also
favors species belonging to the genera Lactobacillus, Corynebacterium, and
Pseudomonas during periodontitis. This
suggests that the alteration of the
periodontal microbiome in diabetic
patients plays a major role in the
pathogenesis of periodontal disease.
3.2. Rheumatoid arthritis
Rheumatoid arthritis has been
associated with periodontitis, and
both diseases have many similarities,
including their inflammatory pathways
as well as genetic and environmental
risk factors. While several studies have
used next-generation sequencing to
demonstrate that the oral microbiome
is altered in rheumatoid arthritis, they
have either failed to include a control population or included individuals with periodontitis or with undetermined periodontal status [19–21].
Because periodontitis itself is a significant modifier of the oral microbiome, these studies make it difficult to
make it difficult to precise whether the
dysbiosis was caused by rheumatoid
arthritis or by periodontitis itself. To
date, the only study to include proper
controls (a nonrheumatoid arthritis
population and periodontally healthy
groups) revealed that when patients
with rheumatoid arthritis and periodontitis were compared with control
patients with periodontitis but not
rheumatoid arthritis, no significant
clustering was observed by principal
component analysis, yet the levels of
pathogenic species, such as Prevotella,
A actinomycetemcomitans, and Parvimonas
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Figure 4 - Bacterial load and microbial diversity in
subgingival biofilm samples. [22]

Figure 5 - Bacterial load and microbial diversity in
subgingival biofilm samples. [27]

micra, as well as the levels of gramnegative anaerobic species, are significantly increased in patients with rheumatoid arthritis (Figure 4) [22].
Studies that have investigated
the influence of rheumatoid arthritis
alone on the periodontal microbiome
are somewhat controversial. Scher et
al. found no significant differences in
microbial diversity and microbial composition when new-onset rheumatoid
arthritis, chronic rheumatoid arthritis,
and healthy control groups were compared [23].
By contrast, Lopez-Oliva et al.
and Corrêa et al. reported significant clustering of the microbiomes
based on rheumatoid arthritis status,
indicating that these groups differed

both with regard to the “community
membership” (presence or absence
of lineages), and to the “community
structure” (relative abundance of lineages within communities). Patients
with rheumatoid arthritis had greater
plaque biomass and an abundance of
both gram-positive and gram-negative
obligate anaerobes, with high levels of
members of the genera Cryptobacterium,
Dialister,
Fretibacterium,
Prevotella
(Prevotella melaninogenica, Prevotella denticola, Prevotella histicola, Prevotella nigrescens,
Prevotella oulorum, and Prevotella maculosa) Treponema [24], and Selenomonas
(Selenomonas noxia and Selenomonas sputigena) [22]. By contrast, several healthassociated species, such as Rothia aeria,
Kingella oralis, and others belonging

to the genera Gemella, Granulicatella,
Haemophilus, Neisseria, Streptococcus, and
Actinomyces were less abundant and
less prevalent in rheumatoid arthritis
[22,24].
Rheumatoid arthritis has also been
examined in the presence and absence
of periodontitis. Although principal
component analysis demonstrated
some separation when patients with
periodontitis, with and without rheumatoid arthritis, and when patients
with rheumatoid arthritis, with and
without periodontitis, were compared,
this was not as evident as that observed
in periodontally healthy patients with
or without rheumatoid arthritis. These
findings suggest that rheumatoid
arthritis is a major modulator driving
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Figure 6 - Prevalence of subgingival microorganisms in HIV-positive and HIVnegative patients with chronic periodontitis.

a healthy microbiome to one that is
pathogenic prior to the establishment
of periodontitis. Subjects with rheumatoid arthritis, without periodontitis,
show 2-fold increases in interleukin-2,
interferon-gamma, tumor necrosis factor, and interleukin-33 compared with
matched controls, which explains, in
part, the chronic inflammatory selective pressure of rheumatoid arthritis
on the microbiome [22].
The precise nature of the dysbiotic
changes is uncertain as there is no
consensus among the limited number of studies conducted; however,
it appears that rheumatoid arthritis
is associated with an increase in the
levels of Prevotella and Selenomonas,
whereas diabetes, as previously discussed, is associated with an increase
in the abundance of Capnocytophaga and
Porphyromonas. To summarize, the oral
microbiome of patients with rheumatoid arthritis is distinct from that of
healthy controls. It is enriched in periodontitis-associated anaerobic organisms, such as those from the genera
Prevotella and Selenomonas, whereas
the abundance of health-associated
organisms, such as those from the

genera Streptococcus, Corynebacterium,
Rothia, and Actinomyces, is lower than in
healthy subjects [22,23].
3.3. Systemic lupus erythematosus
Systemic lupus erythematosus is a
multisystem autoimmune disease with
heterogeneous clinical manifestations
primarily affecting the joints, internal
organs, and the skin [25]. While the
pathogenesis has not been fully elucidated, systemic lupus erythematosus
is characterized by an abundance of
autoreactive CD4+ T-cells, an altered
proinflammatory/anti-inflammatory
cytokine balance, excessive antibody
production, and immune complex
deposition [26]. It has been well documented that the immunity of the oral
mucosa is adversely affected in individuals with systemic lupus erythematosus. In fact, oral ulcers are among the
possible features needed for a formal
diagnosis of systemic lupus erythematosus [25].
To date, few studies have addressed
the effects of systemic lupus erythematosus in the periodontium and on
the oral microbiota. Subjects with
systemic lupus erythematosus show

a prevalence of periodontitis around
70% higher than subjects who do not
have systemic lupus erythematosus,
and demonstrate increased risk for
developing periodontitis. In addition,
more severe forms of periodontitis
have been reported in subjects with
systemic lupus erythematosus [27].
Similarly to other autoimmune diseases, the altered immune response in
systemic lupus erythematosus probably disrupts the balance between the
host and the oral microbiota, favoring a unique dysbiotic condition that
results in an enhanced periodontal
inflammatory response and tissue
destruction. In support of the influence of systemic lupus erythematosus
in the periodontium, individuals with
systemic lupus erythematosus and
a healthy periodontium show higher
proportions of subgingival P nigrescens, P oulorum, Prevotella oris, and S noxia
than controls with a healthy periodontium [27]. In addition, periodontitis in
subjects with systemic lupus erythematosus appears to be distinct from
periodontitis in systemically healthy
controls, with a higher bacterial load
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and reduced (rather than increased)
microbial diversity (Figure 5) [27].
Furthermore, individuals with systemic lupus erythematosus and periodontitis show a shift toward higher
proportions of anaerobic bacteria,
including P oulorum, F fastidiosum, and
Fusobacterium Anaeroglobus geminatus.
Most of the bacterial species found
with elevated proportions in individuals with systemic lupus erythematosus (regardless of the periodontal
condition) were anaerobic (Prevotella,
Selenomonas, and Treponema). These
changes in the oral microbiota have
been linked to increased local inflammation, as demonstrated by higher
concentrations of the salivary cytokines interleukin-6 and interleukin-17
in individuals with systemic lupus
erythematosus and periodontitis compared with controls with periodontitis
[27].
3.4. Human immunodeficiency virus
Human immunodeficiency virus,
a retrovirus, with 85% of infections
occurring through heterosexual transmission, has a profound effect on both
innate and acquired immunity [28].
CD4+ T-cells, macrophages, and dendritic cells may be infected by HIV after
initial transmission, then transported
to regional lymph nodes and released
into the bloodstream [29].
Human immunodeficiency virus
itself and the antiretroviral treatment
for HIV infection have the potential to
alter the diversity and composition of
the oral microbiome through inducing
host-microbe dysbiosis, which might
further link to a variety of different
complications of HIV, including a faster
progression of disease. The commensal bacteria or normal flora bacteria
can act as opportunistic pathogens in
immunosuppressed individuals, with
the oral cavity as a primary site for colonization [30,31].
Lewy et al. used 16S ribosomal
DNA-based pyrosequencing to compare the salivary microbiome in aged
HIV-infected (>50 years of age), young
HIV-infected (<35 years of age), and
age-matched uninfected women. The

abundance of P melaninogenica and
Rothia mucilaginosa was increased in all
ages of HIV-infected women, and bacterial diversity was found to increase
with age. The study also highlighted
that high HIV-RNA levels in plasma
are associated with a shift toward an
increased pathogenic footprint of the
salivary microbiome, while circulating CD4+ T-cell numbers show a positive correlation with the abundance of
potentially beneficial Streptococcus and
Lactobacillus [32].
Another study evaluated the oral
bacteriome in HIV-1-infected and nonHIV-1-infected Brazilian children using
the Ion Torrent PGM platform to analyze the sequence of 16S ribosomal
RNA gene amplicons. Compared with
non–HIV-1-infected individuals, the
oral bacteriome of both sub and supragingival biofilms in HIV-1-infected
participants had increased richness
and complexity, with higher relative
abundance of potentially pathogenic
species Veillonella and Prevotella in the
subgingival biofilm [33].
The relationship of the oral microbiome with the severity of periodontitis
has also been evaluated by NogueraJulian et al. via 16S rRNA gene sequencing in HIV-positive patients. Subtle
oral microbial signatures were identified, including those of Abiotrophia and
Rothia, were enriched in moderate and
severe periodontitis compared with
no/mild periodontitis; and Treponema
spp was also more prevalent in severe
periodontitis when compared to no/
mild periodontitis [34].
Current studies are not enough
to clearly explain the effect of HIV on
periodontal microbiome dysbiosis.
Patel et al. found that HIV-positive
subjects with chronic periodontitis
had lower prevalence of Porphyromonas
gingivalis and Treponema denticola compared to HIV negative subjects with
chronic periodontitis, and no statistical different prevalence of other periodontal pathogens between the two
groups (Figure 6) [31].
One of the main limitations of current studies discussing how HIV affects
the periodontal microbiome seems to

be the small number of subjects in
each study. Given the great diversity
seen between individual microbiota
and the discrepancies between studies, larger cohort studies, and collation of data from multiple studies, may
lead to a more complete understanding of host-microbe dysbiosis in HIV
infection.
3.5. Leucocyte adhesion deficiency
Leukocyte adhesion deficiency type
I (LAD-I) is an autosomal recessive
immunodeficiency disorder characterized by defects in the integrin receptors of white blood cells that lead to
impaired adhesion and chemotaxis.
Affected patients are susceptible to
recurrent bacterial and fungal infections, impaired pus formation, delayed
wound healing, and periodontitis [35].
The subgingival microbiome of
LAD-I patients has been recently characterized by Moutsopoulos et al. using
a 16s rRNA gene-based microarray.
Results of these analyses reveal that
the tooth-associated microbial communities in LAD-I are distinct from
those associated with periodontal
health or aggressive periodontitis in
the general population [36]. Unique
characteristics of the LAD-I microbiome are its increased bacterial load
and the reduced number of species
detected. An increase in microbial load
has also been detected in the subgingival microbiome of chronic periodontitis patients, particularly at sites that
are inflamed and bleeding [37].
However, chronic and aggressive forms or periodontitis in the
absence of immune deficiency are
characterized by increased diversity
and richness in the subgingival biofilm and a significant increase in species detected within the periodontal
microbial communities compared to
those of periodontal health [37,38].
Interestingly, the LAD-I microbiome
shows a decreased diversity of species detected and is dominated by a
complete depletion of a large number
of bacterial species associated with
periodontal health. Classic periodontal health species from several genera
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such as Actinomyces, Rothia, Granulicatella
and Streptococci were undetectable in
LAD-I [37]. LAD communities also do
not resemble communities in chronic
or aggressive periodontitis. The classical periodontitis-associated species (Porphyromonas gingivalis, Treponema
denticola and Tannerella forsythia) were
not detected at high levels in LAD-I
compared to periodontal health [36].
Aggregatibacter
actinomycetemcomitans,
an organism associated with aggressive periodontitis [39], was also not
detected in LAD-I periodontitis.
Moutsopoulos et al. suggest that
the subgingival communities of LAD
can serve as initial triggers for local
immunopathology through translocation of bacterial products into tissues
and stimulation of local IL-23-related
destructive inflammatory responses
[36].
3.6. Liver diseases
Oral dysbiosis has been found in
different liver pathologies like cirrhosis, hepatocellular carcinoma, nonalcoholic fatty liver disease, and viral
liver disease [40].
Liver cirrhosis is the histological transformation of hepatic tissue
developed by the regenerative nodular
tissue formation. This nodular tissue
becomes surrounded by fibrous bands,
as a result of the chronic hepatic injury
that lasts for several years or decades
and, consequently, causes portal
hypertension and end-stage liver disease. It is one of the most widespread
health conditions related to morbidity
and resulting in mortality [41]. Several
diverse etiological factors contribute
to liver cirrhosis. The most predominant include viral hepatitis, alcoholic
liver disease (ALD), and nonalcoholic
fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) [42].
Recent studies have presented
some evidence of a possible relationship between liver diseases and dysbiosis of oral microbiota.
A study conducted by Yoneda et
al. reveals that P. gingivalis (one of the
most common periodontal pathogens)
infection was mostly observed in the

NAFLD positive patients, rather than
the NAFLD negative patients [43]. In
addition, Yoneda et al. demonstrated
through an in vivo mice model that
the P. gingivalis infection was effective in promoting NAFLD progression
towards NASH. Moreover, Nagao et
al. inspected the correlation within
periodontal diseases and liver fibrosis advancement in hepatitis B- and
C-related cirrhosis [44].
Zhao et al. reported a decrease
of the abundance of Bacteroidetes
and an increase of Proteobacteria and
Gracilibacteria in patients affected by
Hepatitis B; the relative abundance
of Actinomyces, Porhyromonas, Bergeyella,
Centipeda, Alysiella, Bulleidia, and
Pseudoramibacter was significantly different in patient with Hepatitis B compared to the healthy controls [45].
Abe et al found a relation between
oral microbial dysbiosis and inflammatory markers in patients affected
by autoimmune liver diseases. In particular, they discovered a significant
increase of genus Veillonella in these
patients ,and a significant association
between the presence of Veillonella and
the levels of salivary IgA, IL-1b, IL-6,
and IL-8 in patients affected by autoimmune hepatitis [46].

4.

Conclusion

The literature clearly shows that a
strong association exists between oral
health and systemic health. One of the
pathogenesis responsible of this association is the alteration of the oral and
periodontal microbiome, even though
there are clearly several knowledge
gaps that exist and need further investigations. This review shows that many
systemic diseases have an impact on
the periodontal microbiome dysbiosis,
with varying degrees of evidence. This
strongly highlights the importance of
knowing about a patient’s health condition before planning the treatment,
as local treatments might be insufficient for many patients, who will
require a multidisciplinary approach.
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